DNM1 and glomerulosclerosis: Podocyte-specific deletion of the AT1aR (Angiotensin II receptor type 1a which is mainly expressed in mice kidney) in Dnm-DKO mice demonstrated reduced albuminuria, improvement in both glomerulosclerosis and kidney function, and attenuation of membrane abnormalities.